Mobile

A randomised, double-blind, placebo-controlled, ascending dose Phase I/IIa study to evaluate the safety, tolerability and efficacy of topical LTX-109 in subjects nasally colonized with methicillin-res...

Update Il y a 4 ans
Reference: EUCTR2010-019254-40

A randomised, double-blind, placebo-controlled, ascending dose Phase I/IIa study to evaluate the safety, tolerability and efficacy of topical LTX-109 in subjects nasally colonized with methicillin-resistant/-sensitive Staphylococcus aureus (MRSA/MSSA)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To determine: • Safety and tolerability of LTX-109 when applied topically to the anterior nares three times daily for three days. • Decolonization, eradication or no eradication of nasal MRSA/MSSA after treatment with LTX-109 over a period of three days • The extent of systemic absorption of LTX-109 after application to the anterior nares.

Inclusion criteria

  • Nasal decolonization of MRSA/MSSA

Links